UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France

PloS one, 2015-06, Vol.10 (6), p.e0128880-e0128880

2015

Volltextzugriff (PDF)

Pharmacogenetics of Capecitabine in Advanced Breast Cancer Patients

Clinical cancer research, 2006-09, Vol.12 (18), p.5496-5502

2006

Volltextzugriff (PDF)

Phase II trial evaluating a docetaxel‐capecitabine combination as treatment for hormone‐refractory prostate cancer

Cancer, 2006-08, Vol.107 (4), p.738-745

2006

Volltextzugriff (PDF)

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

The lancet oncology, 2022-11, Vol.23 (11), p.1367-1377

2022

Volltextzugriff (PDF)

404 Olaparib vs placebo as maintenance therapy after platinum based chemotherapy in advanced/metastatic endometrial cancer patients: the GINECO randomized phase IIb UTOLA trial

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A177-A177

2024

Volltextzugriff (PDF)

555 Association between molecular heterogeneity and prognosis in non-P53 metastatic endometrial carcinoma: ancillary analysis of the UTOLA phase II GINECO trial

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A186-A187

2024

Volltextzugriff (PDF)

Abstract P2-13-26: Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer (BC): First real-life data from the cohort temporary authorization for use (cATU) program in France

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-13-26

2022

Volltextzugriff (PDF)

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

European journal of cancer (1990), 2017-09, Vol.82, p.237-246

2017

Volltextzugriff (PDF)

2022-RA-922-ESGO Histo-molecular characteristics of platinum-sensitive advanced endometrial cancer: data issued from the population included in the GINECO UTOLA study

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A118-A119

2022

Volltextzugriff (PDF)

Multicentre randomized phase II trial of olaparib as maintenance therapy in platinum-sensitive advanced endometrial carcinoma: The GINECO-UTOLA study

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS6109-TPS6109

2020

Volltextzugriff (PDF)

Abstract PD17-02: ctDNA Molecular Response based on breast cancer driver mutations predicts progression in aromatase inhibitor-sensitive first line treatment of oestrogen receptor-positive (ER+) HER2-negative (HER2-) advanced breast cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD17-02-PD17-02

2023

Volltextzugriff (PDF)

Prospective multicenter study of the impact of the Prosigna assay on adjuvant clinical decision-making in women with early stage breast cancer: which patients are the best candidates?

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.543-543

2016

Volltextzugriff (PDF)

Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas

Cancer letters, 2009-01, Vol.273 (2), p.323-330

2009

Volltextzugriff (PDF)

Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France: e0128880

PloS one, 2015-06, Vol.10 (6)

2015

Volltextzugriff (PDF)

Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans

Journal of clinical laboratory analysis, 2008, Vol.22 (6), p.415-420

2008

Volltextzugriff (PDF)

11q13 Alterations in two cases of hibernoma: Large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5

Genes chromosomes & cancer, 2003-08, Vol.37 (4), p.389-395

2003

Volltextzugriff (PDF)

Amifostine Can Reduce Oral Mucositis after High-Dose Melphalan Conditioning in Patients with Multiple Myeloma: A Retrospective Study

Blood, 2004-11, Vol.104 (11), p.5022-5022

2004

Volltextzugriff (PDF)

From cytogenetics to cytogenomics of adipose tissue tumors: 1. Benign adipose tissue tumors

Bulletin du cancer, 2002-07, Vol.89 (7-8), p.689

2002

Volltextzugriff (PDF)

Ceftriaxone monotherapy for the treatment of febrile neutropenia in patients with solid tumors: a prospective study of 100 episodes

Medical science monitor, 2004-11, Vol.10 (11), p.PI119-PI125

2004

Volltextzugriff (PDF)

Primary lung sarcomas: long survivors obtained with iterative complete surgery

Lung cancer (Amsterdam, Netherlands), 2001-02, Vol.31 (2-3), p.241-245

2001

Volltextzugriff (PDF)

Cardiac tolerance of the combination paclitaxel-anthracyclines in the context of the management of cancer of the breast

Bulletin du cancer, 2003-03, Vol.90 (3), p.219

2003

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)
Berichte
(1)

Sprache

Englisch
(31)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(4)
Blood
(3)
International Journal Of Gynecological Cancer
(3)
British Journal Of Haematology
(2)
Bulletin Du Cancer
(2)
Cancer Research
(2)
Journal Of Clinical Oncology
(2)
Breast
(1)
Cancer
(1)
Cancer Genetics And Cytogenetics
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France

Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2–14)

Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers

Trastuzumab deruxtecan in previously treated HER2‐positive metastatic or unresectable breast cancer: Real‐life data from the temporary use authorization program in France

Pharmacogenetics of Capecitabine in Advanced Breast Cancer Patients

Phase II trial evaluating a docetaxel‐capecitabine combination as treatment for hormone‐refractory prostate cancer

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

404 Olaparib vs placebo as maintenance therapy after platinum based chemotherapy in advanced/metastatic endometrial cancer patients: the GINECO randomized phase IIb UTOLA trial

555 Association between molecular heterogeneity and prognosis in non-P53 metastatic endometrial carcinoma: ancillary analysis of the UTOLA phase II GINECO trial

Abstract P2-13-26: Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer (BC): First real-life data from the cohort temporary authorization for use (cATU) program in France

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

2022-RA-922-ESGO Histo-molecular characteristics of platinum-sensitive advanced endometrial cancer: data issued from the population included in the GINECO UTOLA study

Multicentre randomized phase II trial of olaparib as maintenance therapy in platinum-sensitive advanced endometrial carcinoma: The GINECO-UTOLA study

Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna.sup.® Test in the management of early-stage breast cancers

Abstract PD17-02: ctDNA Molecular Response based on breast cancer driver mutations predicts progression in aromatase inhibitor-sensitive first line treatment of oestrogen receptor-positive (ER+) HER2-negative (HER2-) advanced breast cancer

Prospective multicenter study of the impact of the Prosigna assay on adjuvant clinical decision-making in women with early stage breast cancer: which patients are the best candidates?

Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas

Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France: e0128880

Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans

11q13 Alterations in two cases of hibernoma: Large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5

Amifostine Can Reduce Oral Mucositis after High-Dose Melphalan Conditioning in Patients with Multiple Myeloma: A Retrospective Study

From cytogenetics to cytogenomics of adipose tissue tumors: 1. Benign adipose tissue tumors

Ceftriaxone monotherapy for the treatment of febrile neutropenia in patients with solid tumors: a prospective study of 100 episodes

Primary lung sarcomas: long survivors obtained with iterative complete surgery

Cardiac tolerance of the combination paclitaxel-anthracyclines in the context of the management of cancer of the breast

Suchergebnisse filtern